JP7004224B2 - タムスロシン塩酸塩含有徐放性ペレットを含む、溶出率が制御された経口投与用薬剤学的製剤 - Google Patents
タムスロシン塩酸塩含有徐放性ペレットを含む、溶出率が制御された経口投与用薬剤学的製剤 Download PDFInfo
- Publication number
- JP7004224B2 JP7004224B2 JP2019506094A JP2019506094A JP7004224B2 JP 7004224 B2 JP7004224 B2 JP 7004224B2 JP 2019506094 A JP2019506094 A JP 2019506094A JP 2019506094 A JP2019506094 A JP 2019506094A JP 7004224 B2 JP7004224 B2 JP 7004224B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pellets
- tamsulosin hydrochloride
- oral administration
- sustained release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2016-0103269 | 2016-08-12 | ||
KR20160103269 | 2016-08-12 | ||
PCT/KR2017/008800 WO2018030862A1 (ko) | 2016-08-12 | 2017-08-11 | 탐수로신 염산염 함유 서방성 펠렛을 포함하는 용출률이 제어된 경구투여용 약제학적 제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019527700A JP2019527700A (ja) | 2019-10-03 |
JP7004224B2 true JP7004224B2 (ja) | 2022-02-10 |
Family
ID=61163047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019506094A Active JP7004224B2 (ja) | 2016-08-12 | 2017-08-11 | タムスロシン塩酸塩含有徐放性ペレットを含む、溶出率が制御された経口投与用薬剤学的製剤 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20190167612A1 (de) |
EP (1) | EP3498264B1 (de) |
JP (1) | JP7004224B2 (de) |
KR (1) | KR102391496B1 (de) |
CN (1) | CN109562072B (de) |
AU (1) | AU2017308461A1 (de) |
BR (1) | BR112019002635A2 (de) |
EA (1) | EA201990223A1 (de) |
ES (1) | ES2967085T3 (de) |
MX (1) | MX2019001741A (de) |
PH (1) | PH12019500276A1 (de) |
WO (1) | WO2018030862A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102169926B1 (ko) * | 2018-01-12 | 2020-10-26 | 주식회사 종근당 | 탐스로신과 타다라필을 포함하는 약제학적 조성물 |
ES2967689T3 (es) | 2018-04-06 | 2024-05-03 | Capsugel Belgium Nv | Proceso de secado por aspersión para partículas de baja relación de aspecto que comprenden poli[(metacrilato de metilo)-co-(ácido metacrílico)] |
KR20200078121A (ko) | 2018-12-21 | 2020-07-01 | 한미약품 주식회사 | 탐수로신 및 솔리페나신을 포함하는 경구용 복합제제 및 그 제조방법 |
KR20200121183A (ko) | 2019-04-15 | 2020-10-23 | 한미약품 주식회사 | 탐스로신 및 솔리페나신을 포함하는 복합제제 및 그 제조방법 |
KR20210003323A (ko) * | 2019-07-01 | 2021-01-12 | 한미약품 주식회사 | 탐수로신 또는 이의 염산염 함유 제약 조성물 및 이의 제조방법 |
CN113189239B (zh) * | 2021-05-06 | 2023-04-14 | 山东省药学科学院 | 一种用高效液相色谱法测定右兰索拉唑缓释胶囊中小丸i含量的方法 |
CA3235733A1 (en) | 2021-10-25 | 2023-05-04 | Farmalider, S.A. | Tadalafil oral suspension |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007507491A (ja) | 2003-09-29 | 2007-03-29 | シージェー コーポレーション | 徐放性製剤 |
JP2012511039A (ja) | 2008-12-09 | 2012-05-17 | シントン・ベスローテン・フェンノートシャップ | 固定用量組合せのためのタムスロシンペレット剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR930007245A (ko) | 1991-09-16 | 1993-04-22 | 강진구 | 영상신호 수신 장치 |
KR100762846B1 (ko) * | 2003-09-29 | 2007-10-04 | 씨제이 주식회사 | 서방성 제제 |
KR100570419B1 (ko) * | 2004-01-14 | 2006-04-11 | 코오롱제약주식회사 | 염산 탐술로신의 경구 투여용 서방성 펠렛 조성물 및 그제조방법 |
KR100582350B1 (ko) | 2004-02-17 | 2006-05-22 | 한미약품 주식회사 | 탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제 |
KR20060093931A (ko) * | 2005-02-23 | 2006-08-28 | 센츄론(주) | 펠렛타입의 방출제어형 탐술로신 제제 |
KR100912680B1 (ko) * | 2006-03-16 | 2009-08-19 | (주) 벡스코아 | 제어 방출 제형 |
KR101686033B1 (ko) * | 2010-04-12 | 2016-12-13 | 주식회사 대웅제약 | 탐술로신 또는 이의 약제학적 허용 가능한 염을 유효성분으로 함유하는 장용성 서방형 펠렛부와 속방부로 이루어진 의약 조성물 |
CN103585112B (zh) * | 2012-08-14 | 2015-08-12 | 齐鲁制药有限公司 | 一种坦洛新肠溶缓释微丸及其制备方法 |
KR20160100570A (ko) * | 2015-02-16 | 2016-08-24 | 한미약품 주식회사 | 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제 |
-
2017
- 2017-08-11 JP JP2019506094A patent/JP7004224B2/ja active Active
- 2017-08-11 WO PCT/KR2017/008800 patent/WO2018030862A1/ko unknown
- 2017-08-11 CN CN201780049450.1A patent/CN109562072B/zh active Active
- 2017-08-11 ES ES17839879T patent/ES2967085T3/es active Active
- 2017-08-11 BR BR112019002635A patent/BR112019002635A2/pt active Search and Examination
- 2017-08-11 KR KR1020170102553A patent/KR102391496B1/ko active IP Right Grant
- 2017-08-11 US US16/324,648 patent/US20190167612A1/en not_active Abandoned
- 2017-08-11 EA EA201990223A patent/EA201990223A1/ru unknown
- 2017-08-11 MX MX2019001741A patent/MX2019001741A/es unknown
- 2017-08-11 EP EP17839879.8A patent/EP3498264B1/de active Active
- 2017-08-11 AU AU2017308461A patent/AU2017308461A1/en not_active Abandoned
-
2019
- 2019-02-08 PH PH12019500276A patent/PH12019500276A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007507491A (ja) | 2003-09-29 | 2007-03-29 | シージェー コーポレーション | 徐放性製剤 |
JP2012511039A (ja) | 2008-12-09 | 2012-05-17 | シントン・ベスローテン・フェンノートシャップ | 固定用量組合せのためのタムスロシンペレット剤 |
Also Published As
Publication number | Publication date |
---|---|
KR20180018450A (ko) | 2018-02-21 |
EP3498264A4 (de) | 2020-03-11 |
ES2967085T3 (es) | 2024-04-26 |
MX2019001741A (es) | 2019-12-09 |
WO2018030862A1 (ko) | 2018-02-15 |
CN109562072B (zh) | 2022-04-05 |
EP3498264B1 (de) | 2023-11-08 |
KR102391496B1 (ko) | 2022-04-28 |
EP3498264A1 (de) | 2019-06-19 |
EA201990223A1 (ru) | 2019-07-31 |
PH12019500276A1 (en) | 2019-05-15 |
AU2017308461A1 (en) | 2019-02-28 |
BR112019002635A2 (pt) | 2019-05-28 |
JP2019527700A (ja) | 2019-10-03 |
CN109562072A (zh) | 2019-04-02 |
US20190167612A1 (en) | 2019-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7004224B2 (ja) | タムスロシン塩酸塩含有徐放性ペレットを含む、溶出率が制御された経口投与用薬剤学的製剤 | |
JP6453380B2 (ja) | ヒドロコドン放出制御製剤 | |
JP2008528494A (ja) | 医薬製剤および使用方法 | |
MX2007001850A (es) | Formulacion de pildora de liberacion prolongada que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para fabricarlo y uso del mismo. | |
JP2003503341A (ja) | 少なくとも一つの適時パルスを生ずる制御された放出用の医薬投与形態 | |
JP2005512997A (ja) | タムスロシン錠 | |
JP2009504729A (ja) | α1受容体拮抗薬の徐放性ペレット製剤及びその製造方法 | |
KR20070115918A (ko) | 멀티플 유닛형 경구 서방성 제제 및 그 제조방법 | |
JP5687185B2 (ja) | 多粒子系を含む二段階の放出プロフィールを有する固形経口剤 | |
TW201206501A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
WO2007080776A1 (ja) | 徐放性製剤およびその製造方法 | |
WO2010129689A1 (en) | Milnacipran formulations | |
JP2019524683A (ja) | 含量均一性が改善されたタムスロシン塩酸塩含有徐放性ペレットを含む経口用薬剤学的製剤 | |
JP6924177B2 (ja) | 医薬組成物粒子とそれを含む口腔内崩壊製剤 | |
KR20040032977A (ko) | 신규 지연 방출 경구 투여 제형 | |
JP2018508501A (ja) | タムスロシン塩酸塩含有徐放性顆粒を含む経口用薬剤学的製剤 | |
KR102246658B1 (ko) | 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제 | |
US8980318B2 (en) | Neramexane multiple unit dosage form | |
JP5919173B2 (ja) | 徐放性塩酸アンブロキソール口腔内崩壊錠 | |
JP7182550B2 (ja) | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 | |
EA043575B1 (ru) | Фармацевтическая композиция для перорального приема с контролируемой скоростью растворения, содержащая пеллеты с замедленным высвобождением, содержащие тамсулозина гидрохлорид | |
AU2022315552A1 (en) | Multiparticulate pharmaceutical composition | |
KR20220015437A (ko) | 피리미디닐아미노-피라졸 화합물의 변형 방출 제제, 및 치료 방법 | |
WO2008102235A1 (en) | Controlled release formulations of alfuzosin | |
CN108066347A (zh) | 包含坦索罗辛和度他雄胺的口腔崩解片药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190213 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200408 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210302 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210602 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211130 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211215 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7004224 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |